Profusa withdraws $15 million public offering for smaller fundraise

Go back to Profusa withdraws $15 million public offering for smaller fundraise

Profusa To Withdraw S-1 Registration Statement to Pursue a Smaller, More Focused Offering

February 27, 2026 9:15 AM EST

After Reevaluating its Near-term Capital Needs Given the Recent Changes in its Projected 2026 Revenue and Mayo Collaboration, the Company Determined that a $15 Million Offering is Not Required to Achieve Near-term Revenue Projections

BERKELEY, CA, Feb. 27, 2026 (GLOBE NEWSWIRE) -- Profusa, Inc. (Profusa or the Company) (Nasdaq: PFSA), a commercial stage digital health company pioneering the next generation of technology platform enabling the continuous monitoring of an individuals biochemistry, announces it has elected not to proceed with its public offering and intends to file a post-effective amendment with the U.S.... More